Jennifer Gershman, PharmD, CPh, received her PharmD degree from Nova Southeastern University (NSU) College of Pharmacy in 2006 and completed a 2-year drug information residency. She served as a pharmacy professor at NSU's College of Pharmacy for 6 years, managed the drug information center, and conducted medication therapy management reviews. Dr. Gershman has published research on prescription drug abuse, regulatory issues, and drug information in various scholarly journals. Additionally, she received the Sheriff's Special Recognition Award for her collaboration with the Broward, Florida Sheriff's Office to prevent prescription drug abuse through a drug disposal program. She has also presented at pharmacist and physician continuing education programs on topics that include medication errors, prescription drug abuse, and legal and regulatory issues. Dr. Gershman can be followed on Twitter @jgershman2
The 9-Valent HPV Recombinant Vaccine: An Introduction
March 1st 2018The 9-valent human papillomavirus (HPV) recombinant vaccine (Gardasil 9, Merck & Company, Inc.) is indicated for women and men aged 9 to 26 years for the prevention of certain diseases, precancerous lesions, and genital warts caused by HPV.
Read More